# Factset Research Systems Inc: financial statements, quarterly

FDS · NYSE · CIK 1013237 · [Technology](/sectors/technology.md) · fiscal year ends Aug 31

Pages: [Overview](/companies/fds.md) · [Financials](/companies/fds/financials.md) · [Filings](/companies/fds/filings.md) · [Insiders](/companies/fds/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fds/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) | Q4 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [542](/filings/0001013237-25-000010.md) | [546](/filings/0001013237-25-000051.md) | [553](/filings/0001013237-25-000070.md) | [562 d](/filings/0001628280-26-066391.md) | [569](/filings/0001628280-26-000223.md) | [571](/filings/0001628280-26-022873.md) | [586](/filings/0001628280-26-046549.md) | [597 d](/filings/0001628280-26-066391.md) | [608](/filings/0001628280-26-000223.md) | [611](/filings/0001628280-26-022873.md) | [623](/filings/0001628280-26-046549.md) | [635 d](/filings/0001628280-26-066391.md) |
| Cost of revenue | $m | [252](/filings/0001013237-25-000010.md) | [255](/filings/0001013237-25-000051.md) | [247](/filings/0001013237-25-000070.md) | [258 d](/filings/0001628280-26-066391.md) | [259](/filings/0001628280-26-000223.md) | [270](/filings/0001628280-26-022873.md) | [281](/filings/0001628280-26-046549.md) | [289 d](/filings/0001628280-26-066391.md) | [288](/filings/0001628280-26-000223.md) | [297](/filings/0001628280-26-022873.md) | [312](/filings/0001628280-26-046549.md) | [326 d](/filings/0001628280-26-066391.md) |
| Selling, general and administrative | $m | [102](/filings/0001013237-25-000010.md) | [109](/filings/0001013237-25-000051.md) | [103](/filings/0001013237-25-000070.md) | [176 d](/filings/0001628280-26-066391.md) | [119](/filings/0001628280-26-000223.md) | [116](/filings/0001628280-26-022873.md) | [111](/filings/0001628280-26-046549.md) | [131 d](/filings/0001628280-26-066391.md) | [128](/filings/0001628280-26-000223.md) | [129](/filings/0001628280-26-022873.md) | [144](/filings/0001628280-26-046549.md) | [152 d](/filings/0001628280-26-066391.md) |
| Operating income | $m | [189](/filings/0001013237-25-000010.md) | [182](/filings/0001013237-25-000051.md) | [202](/filings/0001013237-25-000070.md) | [128 d](/filings/0001628280-26-066391.md) | [191](/filings/0001628280-26-000223.md) | [185](/filings/0001628280-26-022873.md) | [194](/filings/0001628280-26-046549.md) | [177 d](/filings/0001628280-26-066391.md) | [192](/filings/0001628280-26-000223.md) | [185](/filings/0001628280-26-022873.md) | [166](/filings/0001628280-26-046549.md) | [157 d](/filings/0001628280-26-066391.md) |
| Interest expense | $m | [16.7](/filings/0001013237-24-000009.md) | [16.6](/filings/0001013237-24-000049.md) | [16.9](/filings/0001013237-25-000070.md) | [15.5 d](/filings/0001628280-26-066391.md) | [14.4](/filings/0001628280-26-000223.md) | [13.9](/filings/0001628280-26-022873.md) | [15.1](/filings/0001628280-26-046549.md) | [12.9 d](/filings/0001628280-26-066391.md) | [13.4](/filings/0001628280-26-000223.md) | [13.1](/filings/0001628280-26-022873.md) | [13.8](/filings/0001628280-26-046549.md) | [14.4 d](/filings/0001628280-26-066391.md) |
| Income tax | $m | [26.6](/filings/0001013237-25-000010.md) | [27.7](/filings/0001013237-25-000051.md) | [32.4](/filings/0001013237-25-000070.md) | [27.6 d](/filings/0001628280-26-066391.md) | [29.7](/filings/0001628280-26-000223.md) | [27.5](/filings/0001628280-26-022873.md) | [31.4](/filings/0001628280-26-046549.md) | [35.3 d](/filings/0001628280-26-066391.md) | [37.5](/filings/0001628280-26-000223.md) | [28.1](/filings/0001628280-26-022873.md) | [27.4](/filings/0001628280-26-046549.md) | [23.2 d](/filings/0001628280-26-066391.md) |
| Net income | $m | [149](/filings/0001013237-25-000010.md) | [141](/filings/0001013237-25-000051.md) | [158](/filings/0001013237-25-000070.md) | [89.5 d](/filings/0001628280-26-066391.md) | [150](/filings/0001628280-26-000223.md) | [145](/filings/0001628280-26-022873.md) | [149](/filings/0001628280-26-046549.md) | [154 d](/filings/0001628280-26-066391.md) | [153](/filings/0001628280-26-000223.md) | [133](/filings/0001628280-26-022873.md) | [127](/filings/0001628280-26-046549.md) | [121 d](/filings/0001628280-26-066391.md) |
| Diluted EPS | $ per share | [3.84](/filings/0001013237-25-000010.md) | [3.65](/filings/0001013237-25-000051.md) | [4.09](/filings/0001013237-25-000070.md) | not reported | [3.89](/filings/0001628280-26-000223.md) | [3.76](/filings/0001628280-26-022873.md) | [3.87](/filings/0001628280-26-046549.md) | not reported | [4.06](/filings/0001628280-26-000223.md) | [3.59](/filings/0001628280-26-022873.md) | [3.50](/filings/0001628280-26-046549.md) | not reported |
| Basic EPS | $ per share | [3.91](/filings/0001013237-25-000010.md) | [3.70](/filings/0001013237-25-000051.md) | [4.15](/filings/0001013237-25-000070.md) | not reported | [3.95](/filings/0001628280-26-000223.md) | [3.81](/filings/0001628280-26-022873.md) | [3.92](/filings/0001628280-26-046549.md) | not reported | [4.08](/filings/0001628280-26-000223.md) | [3.60](/filings/0001628280-26-022873.md) | [3.51](/filings/0001628280-26-046549.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) | FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [412](/filings/0001013237-24-000009.md) | [382](/filings/0001013237-25-000051.md) | [453](/filings/0001013237-25-000070.md) | [423](/filings/0001628280-26-066391.md) | [289](/filings/0001628280-26-000223.md) | [279](/filings/0001628280-26-022873.md) | [356](/filings/0001628280-26-046549.md) | [338](/filings/0001628280-26-066391.md) | [275](/filings/0001628280-26-000223.md) | [268](/filings/0001628280-26-022873.md) | [288](/filings/0001628280-26-046549.md) | [233](/filings/0001628280-26-066391.md) |
| Current assets | $m | [766](/filings/0001013237-24-000009.md) | [823](/filings/0001013237-24-000049.md) | [858](/filings/0001013237-24-000084.md) | [836](/filings/0001628280-25-045769.md) | [751](/filings/0001013237-25-000010.md) | [708](/filings/0001013237-25-000051.md) | [760](/filings/0001013237-25-000070.md) | [730](/filings/0001628280-26-066391.md) | [709](/filings/0001628280-26-000223.md) | [724](/filings/0001628280-26-022873.md) | [728](/filings/0001628280-26-046549.md) | [652](/filings/0001628280-26-066391.md) |
| Total assets | $m | [3,951](/filings/0001013237-24-000009.md) | [3,991](/filings/0001013237-24-000049.md) | [4,040](/filings/0001013237-24-000084.md) | [4,055](/filings/0001628280-26-066391.md) | [4,049](/filings/0001013237-25-000010.md) | [4,241](/filings/0001013237-25-000051.md) | [4,339](/filings/0001013237-25-000070.md) | [4,304](/filings/0001628280-26-066391.md) | [4,221](/filings/0001628280-26-000223.md) | [4,220](/filings/0001628280-26-022873.md) | [4,192](/filings/0001628280-26-046549.md) | [4,140](/filings/0001628280-26-066391.md) |
| Current liabilities | $m | [456](/filings/0001013237-24-000009.md) | [460](/filings/0001013237-24-000049.md) | [672](/filings/0001013237-24-000084.md) | [667](/filings/0001628280-25-045769.md) | [538](/filings/0001013237-25-000010.md) | [482](/filings/0001013237-25-000051.md) | [519](/filings/0001013237-25-000070.md) | [521](/filings/0001628280-26-066391.md) | [459](/filings/0001628280-26-000223.md) | [506](/filings/0001628280-26-022873.md) | [1,065](/filings/0001628280-26-046549.md) | [1,090](/filings/0001628280-26-066391.md) |
| Total liabilities | $m | [2,250](/filings/0001013237-24-000009.md) | [2,189](/filings/0001013237-24-000049.md) | [2,149](/filings/0001013237-24-000084.md) | [2,143](/filings/0001628280-25-045769.md) | [2,057](/filings/0001013237-25-000010.md) | [2,185](/filings/0001013237-25-000051.md) | [2,184](/filings/0001013237-25-000070.md) | [2,118](/filings/0001628280-26-066391.md) | [2,053](/filings/0001628280-26-000223.md) | [2,091](/filings/0001628280-26-022873.md) | [2,160](/filings/0001628280-26-046549.md) | [2,138](/filings/0001628280-26-066391.md) |
| Long-term debt | $m | [1,551](/filings/0001013237-24-000009.md) | [1,489](/filings/0001013237-24-000049.md) | [1,241](/filings/0001013237-24-000084.md) | [1,241](/filings/0001628280-25-045769.md) | [1,297](/filings/0001013237-25-000010.md) | [1,472](/filings/0001013237-25-000051.md) | [1,430](/filings/0001013237-25-000070.md) | [1,368](/filings/0001628280-26-066391.md) | [1,369](/filings/0001628280-26-000223.md) | [1,369](/filings/0001628280-26-022873.md) | [891](/filings/0001628280-26-046549.md) | [871](/filings/0001628280-26-066391.md) |
| Current portion of debt | $m | not reported | not reported | [187](/filings/0001013237-24-000084.md) | [125](/filings/0001628280-25-045769.md) | [62.5](/filings/0001013237-25-000010.md) | [0.0](/filings/0001013237-25-000051.md) | [0.0](/filings/0001013237-25-000070.md) | [0.0](/filings/0001628280-26-066391.md) | not reported | not reported | [499](/filings/0001628280-26-046549.md) | [499](/filings/0001628280-26-066391.md) |
| Shareholders' equity | $m | [1,701](/filings/0001013237-25-000051.md) | [1,802](/filings/0001013237-25-000070.md) | [1,890](/filings/0001013237-25-000070.md) | [1,912](/filings/0001628280-26-066391.md) | [1,992](/filings/0001628280-26-022873.md) | [2,057](/filings/0001628280-26-046549.md) | [2,155](/filings/0001628280-26-046549.md) | [2,186](/filings/0001628280-26-066391.md) | [2,168](/filings/0001628280-26-022873.md) | [2,129](/filings/0001628280-26-046549.md) | [2,032](/filings/0001628280-26-046549.md) | [2,002](/filings/0001628280-26-066391.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) | Q4 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [155](/filings/0001013237-25-000010.md) | [144 d](/filings/0001013237-25-000051.md) | [238 d](/filings/0001013237-25-000070.md) | [163 d](/filings/0001628280-26-066391.md) | [86.4](/filings/0001628280-26-000223.md) | [174 d](/filings/0001628280-26-022873.md) | [254 d](/filings/0001628280-26-046549.md) | [212 d](/filings/0001628280-26-066391.md) | [121](/filings/0001628280-26-000223.md) | [212 d](/filings/0001628280-26-022873.md) | [285 d](/filings/0001628280-26-046549.md) | [205 d](/filings/0001628280-26-066391.md) |
| Capital expenditure | $m | [16.5](/filings/0001013237-25-000010.md) | [21.9 d](/filings/0001013237-25-000051.md) | [21.3 d](/filings/0001013237-25-000070.md) | [26.0 d](/filings/0001628280-26-066391.md) | [25.9](/filings/0001628280-26-000223.md) | [23.7 d](/filings/0001628280-26-022873.md) | [25.2 d](/filings/0001628280-26-046549.md) | [34.0 d](/filings/0001628280-26-066391.md) | [30.8](/filings/0001628280-26-000223.md) | [26.0 d](/filings/0001628280-26-022873.md) | [30.5 d](/filings/0001628280-26-046549.md) | [27.4 d](/filings/0001628280-26-066391.md) |
| Dividends paid | $m | [37.1](/filings/0001013237-25-000010.md) | [37.1 d](/filings/0001013237-25-000051.md) | [37.2 d](/filings/0001013237-25-000070.md) | [39.4 d](/filings/0001628280-26-066391.md) | [39.2](/filings/0001628280-26-000223.md) | [39.6 d](/filings/0001628280-26-022873.md) | [39.5 d](/filings/0001628280-26-046549.md) | [41.6 d](/filings/0001628280-26-066391.md) | [41.4](/filings/0001628280-26-000223.md) | [41.0 d](/filings/0001628280-26-022873.md) | [40.3 d](/filings/0001628280-26-046549.md) | [41.5 d](/filings/0001628280-26-066391.md) |
| Share repurchases | $m | [59.9](/filings/0001013237-25-000010.md) | [52.3 d](/filings/0001013237-25-000051.md) | [59.8 d](/filings/0001013237-25-000070.md) | [63.3 d](/filings/0001628280-26-066391.md) | [48.8](/filings/0001628280-26-000223.md) | [64.4 d](/filings/0001628280-26-022873.md) | [80.7 d](/filings/0001628280-26-046549.md) | [107 d](/filings/0001628280-26-066391.md) | [140](/filings/0001628280-26-000223.md) | [163 d](/filings/0001628280-26-022873.md) | [203 d](/filings/0001628280-26-046549.md) | [138 d](/filings/0001628280-26-066391.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-11-30) | Q2 FY2023 (2023-02-28) | Q3 FY2023 (2023-05-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [38.9](/filings/0001013237-24-000009.md) | [39.0](/filings/0001013237-24-000049.md) | [38.9](/filings/0001013237-24-000084.md) | [38.6](/filings/0001013237-25-000010.md) | [38.7](/filings/0001013237-25-000051.md) | [38.6](/filings/0001013237-25-000070.md) | [38.5](/filings/0001628280-26-000223.md) | [38.5](/filings/0001628280-26-022873.md) | [38.3](/filings/0001628280-26-046549.md) | [37.6](/filings/0001628280-26-000223.md) | [37.1](/filings/0001628280-26-022873.md) | [36.2](/filings/0001628280-26-046549.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,255,660 at 2026-10-15, from the cover of the [10-K filed 2026-10-20](/filings/0001628280-26-066391.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.